Ozempic changes taste sensitivity for women with obesity
Semaglutide — a popular weekly injection used for diabetes and weight loss — changes the taste sensitivity, taste perception and the brain’s response to sweet tastes in women with obesity, according to new research presented at the Endocrine Society’s annual meeting in Boston.
“People with obesity often perceive tastes less ‘intensely,’ and they have an inherently elevated desire for sweet and energy-dense food,” explained Mojca Jensterle Sever, Ph.D., of the University Medical Centre in Ljubljana, Slovenia.
Semaglutide — sold under brand names like Ozempic and Wegovy — reduces appetite and lowers the desire for energy-dense, salty and spicy foods, the researchers said.
Full story: Eureka Alert
The article presented here is intended to inform you about the broader media perspective on dentistry, regardless of its alignment with the ADA's stance. It is important to note that publication of an article does not imply the ADA's endorsement, agreement, or promotion of its content.